How UTMD measures up against value, income, timing, and long-hold tenets. Every criterion shows the number as of the last close and the pass rule. Always free.
The tenets below and the 0-100 Tenet Score on this report are two separate computations: each tenet runs its own criteria and its own pass rule, while the score is a percentile composite reported as one of four verdict words (Strong, Solid, Mixed or Weak).
1 / 17 qualify todayas of close, Nov 16, 2026 · computed nightly from our fundamentals DB; point-in-time auditable.
QUALIFIES
1
meet every gate today
BORDERLINE
12
within one input of the gate
FAILS
4
miss at least one gate
UNKNOWN
0
insufficient data to judge
✓passes·✕fails·~borderline·—unknown
Growth receipts arrive in a coming release
Value — six classic philosophies
Buffett Qualitydurable moat
~ Borderline›
✕FailsROE ≥ 15%(fiscal 2025: a quarter is missing from the last four)9.5% · ≥ 15.0%
✓PassesGross margin ≥ 40%(fiscal 2025: a quarter is missing from the last four)57.1% · ≥ 40.0%
✓PassesNet margin ≥ 15%(fiscal 2025: a quarter is missing from the last four)29.3% · ≥ 15.0%
✓PassesDebt/equity ≤ 0.5(fiscal 2025: a quarter is missing from the last four)0.00 · ≤ 0.50
✕FailsGrowing FCF (multi-yr)(fiscal 2020 to 2025)−5.8% per year · > 0
✕FailsOff its 52-week high by 8–35% (a dip, not a collapse)6.4% · 8.0%–35.0%
✕FailsDip within its own normal pullback band0.13
✓PassesNot past where its dips have historically recovered from0.38
✓PassesA dip in an uptrend (above a rising 200-day)68.59
✓PassesHigher-low structure still intactstructure intact · higher low
✓PassesClear of the earnings blackout (more than 5 days out)80.00 · > 5.00
Decided by the pass rule for Drawdown Context.
The pass rule for Drawdown Context is what decides that verdict, and it is not published separately on the methodology page.
Reversal Evidencedaily close onlysigns the pullback is turning
~ Borderline›
✓PassesA bullish MACD cross within 10 sessions4.00 · ≤ 10.00
✕FailsReclaimed a rising 50-day EMA72.43
✓PassesPrinted a higher lowyes
✕FailsA volume thrust on the turn (≥ 1.2× normal)1.13 · ≥ 1.20
✕FailsReversal signals fired: 3 of 4 (MACD·MA·HL·Vol)2.00 · ≥ 3.00
Decided by the pass rule for Reversal Evidence.
The pass rule for Reversal Evidence is what decides that verdict, and it is not published separately on the methodology page.
Not-a-Value-Trap Gatecheap for a good reason, not a broken one
✕ Fails›
✓PassesIn the cheap half of its own 5-year valuation range(through fiscal 2025)0.2×
—Not scored: see the reason belowEarnings estimates not being cutNo analyst estimate revisions are on file for this company yet, so there is nothing to read a trend from.—
✕FailsReturns on capital not deteriorating0.08
Decided by the pass rule for Not-a-Value-Trap Gate.
The pass rule for Not-a-Value-Trap Gate is what decides that verdict, and it is not published separately on the methodology page. 1 of 3 carry no data.
Quality Floorpasses the quality/value gate on this dip
~ Borderline›
✓PassesOperating profit is positive(fiscal 2025: a quarter is missing from the last four)$11.4M · > 0
✕FailsReturn on invested capital ≥ 10%(fiscal 2025: a quarter is missing from the last four)7.6% · ≥ 10.0%
✓PassesA solvent balance sheet (Altman Z ≥ 1.8, net debt/EBITDA ≤ 4)(fiscal 2025: a quarter is missing from the last four)35.9×
✓PassesQuality score ≥ 5068.30 · ≥ 50.00
✕FailsRevenue growing over 5 years(fiscal 2020 to 2025)−1.8% per year · > 0
Decided by the pass rule for Quality Floor.
The pass rule for Quality Floor is what decides that verdict, and it is not published separately on the methodology page.
Qualified Dipa pullback with receipts, not a falling knife
~ Borderline›
A research signal from published criteria, not a recommendation.
✕FailsDrawdown context6.4% off its 52-week high
✕FailsReversal evidence2 of 4 signals fired
✕FailsTrap gate1 of 3 held · 1 no data
✕FailsQuality floor3 of 5 held
Invalidation level (structure break): below this the dip's structure has broken$64.18
✓Passes50-day average above the 200-day (uptrend stack)73.02
✓Passes50-day average sloping up0.01 · > 0
Decided by the pass rule for Trend Alignment.
The pass rule for Trend Alignment is what decides that verdict, and it is not published separately on the methodology page.
Relative Strengthoutperforming, ranked vs the universe
✓ Qualifies›
✓Passes3-month return in the top half of the universe0.70 · ≥ 0.50
✓Passes12-minus-1 momentum in the top half of the universe0.77 · ≥ 0.50
✓PassesRelative strength vs the S&P 500 improving0.00 · > 0
—Not scored: see the reason belowEarnings estimates being revised upNo analyst estimate revisions are on file for this company yet, so there is nothing to read a trend from.—
Decided by the pass rule for Relative Strength.
The pass rule for Relative Strength is what decides that verdict, and it is not published separately on the methodology page. 1 of 4 carry no data.
Momentum Triggera trigger you can see
✕ Fails›
✓PassesMACD above its signal line−0.20
✕FailsBack above the 50-day on a fresh cross (≤10 sessions)4.00
✓PassesHigher high and higher low (stair-stepping up)higher high · higher low
✕FailsA volume thrust on the move (≥ 1.2× normal)1.13 · ≥ 1.20
Decided by the pass rule for Momentum Trigger.
The pass rule for Momentum Trigger is what decides that verdict, and it is not published separately on the methodology page.
Volatility Regimecontext, not a signal
Context, not scored›
Average daily swing: normal0.02
Volatility band width: mid-range0.78
Distance from its 52-week high: a modest pullback0.06
✓
Every verdict is auditableEach criterion shows the number as of the last close and the pass rule side by side: a receipt, not a rating. Several of these screens publish their rule in full under The screens; each row links to its own section where there is one.
!
Unknown ≠ failAn “— Unknown” verdict means the inputs were insufficient: context, not a signal, and never counted as a fail.
Common questions
How many investing rule sets does Utah Medical Products pass?
Utah Medical Products qualifies on 1 of 17 rule sets as of 2026-11-16, with 12 borderline and 4 failing.
Does Utah Medical Products meet the Graham Defensive criteria?
Utah Medical Products fails the Graham Defensive rule set as of 2026-11-16.
Does Utah Medical Products meet the Buffett Quality criteria?
Utah Medical Products is borderline on the Buffett Quality rule set as of 2026-11-16.
Computed from our fundamentals DB; historical-CAGR PEG basis for Lynch. Research, not investment advice. Tenet's rulesets are independently developed from publicly available sources, and Tenet is not affiliated with, sponsored by, endorsed by or otherwise associated with any referenced investor or trademark owner. Full notice. MAGIC FORMULA is a trademark of MagicFormulaInvesting.com LLC.